Albireo Pharma
Gothenburg
About Albireo Pharma
Albireo Pharma is a rare disease company dedicated to the discovery and development of novel bile acid modulators for the treatment of pediatric and adult liver diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $85.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2017)
- Ticker: nasdaq:ALBO
- Website: albireopharma.com
- Phone: 46 3 17 41 14 80
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/albireo-pharma-162474 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.